GlassScriptPhysician profile
Maria M D'Angelo
NPI 1003366303
$1,783.48
in general payments reported to CMS, 2019-2025
33 companies · $71.77 in 2025
The $71.77 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $687 · 2022: $948 · 2023: $75.82 · 2025: $71.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $320.91 | 2021-2022 | |
| Sk Life Science, INC. | $226.30 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $221.92 | 2021-2023 | Austedo |
| Amgen INC. | $144.78 | 2021-2023 | Aimovig |
| Avanir Pharmaceuticals, INC. | $103.85 | 2021-2022 | |
| Ucb, INC. | $82.58 | 2021-2022 | |
| Boston Scientific Corporation | $71.77 | 2025 | Lux-Dx Insertable Cardiac Monitor |
| Biogen, INC. | $58.66 | 2021-2022 | |
| Lilly USA, LLC | $50.11 | 2022 | |
| Genzyme Corporation | $43.33 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $39.75 | 2022 | |
| Grifols USA, LLC | $29.06 | 2022 | |
| Harmony Biosciences LLC | $28.57 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.60 | 2021-2022 | |
| Greenwich Biosciences, INC. | $24.50 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $22.21 | 2022 | |
| Genentech USA, INC. | $21.83 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.06 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.47 | 2022 | |
| Csl Behring | $18.42 | 2022 | |
| Acorda Therapeutics, INC | $18.39 | 2022 | |
| Avion Pharmaceuticals | $18.00 | 2023 | Dhivy |
| Jazz Pharmaceuticals INC. | $17.87 | 2022 | |
| Neurelis, INC. | $17.84 | 2022 | |
| Pfizer INC. | $17.55 | 2023 | |
| Upsher-Smith Laboratories LLC | $17.54 | 2022 | |
| Kyowa Kirin, INC. | $16.25 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.25 | 2022 | |
| Grt US Holding, INC. | $16.17 | 2021 | |
| Adamas Pharmaceuticals, INC. | $14.72 | 2021 | |
| Lundbeck LLC | $14.43 | 2021 | |
| Allergan, INC. | $12.64 | 2022 | |
| Amneal Pharmaceuticals LLC | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria D'Angelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.